Seattle, Washington-based Cell Therapeutics Inc. (NASDAQ: CTIC) is engaged in the development, acquisition and commercialization of treatments for cancer. The company focuses on creating a diversified portfolio of oncology drugs. Through its research and development activities, the company concentrates on identifying and developing less toxic cancer treatments.
Last week, Cell Therapeutics reported its second-quarter financial results [...]

YRC Worldwide Inc. (NASDAQ: YRCW), the Overland Park, Kansas-based transportation company, reported its second-quarter financial results, on Tuesday. The company reported a net loss of $9.5 million, or $0.01 per share, for the second quarter of 2010, compared with a net loss of $309 million, or $5.20 per share reported for the second quarter of [...]

Solarfun Power Holdings Co. Ltd. (NASDAQ: SOLF) shares spiked by 8% after the company posted its second-quarter earnings and announced a strategic investment from Hanwha Chemical.
Solarfun earned $40.2 million or 69 cents per ADS (American depository share) in second-quarter revenue, more than doubling from the prior year to $258.5 million. Adjusted EPS was 59 cents, [...]

First Solar Inc. (NASDAQ: FSLR) recently reported its second-quarter financial results, posting second-quarter net sales of $587.9 million, up 12% from the second quarter of 2009. The increase in second-quarter revenues is primarily due to increased production volumes and systems revenue, partially offset by a decline in pricing and lower euro exchange rate.
First Solar reported [...]

Citigroup Inc. (NYSE: C), last Friday, reported its second-quarter financial reports. The New York City-based banking giant reported second-quarter net income of $2.7 billion, or $0.09 per diluted share. The bank reported second-quarter revenue of $22.1 billion. This is the second consecutive profitable quarter for Citigroup.
Citigroup’s revenue dropped $3.4 billion, while its net income fell [...]

Somaxon Pharmaceuticals Inc. (NASDAQ: SOMX) yesterday announced the establishment of a commercial team to promote Silenor® (doxepin) for the treatment of insomnia.
Somaxan reported that it has entered into a Professional Detailing Services Agreement with Publicis Touchpoint Solutions Inc. Under the agreement, Somaxon will be provided with 100 sales representatives by Publicis on a contract basis. [...]

Single Touch Systems Inc (OTC BB:SITO) stock price reached its 2010 high of $1.52 on June 24 and since then corrected down to  trade in the range of $1.25 in July. Altogether SITO’s stock price increased approximately 150% from April 12’s $0.50 to July 7’s $1.26. The price growth was driven by solid messaging traffic [...]